Literature DB >> 2516007

Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth.

M Nazim1, G Stamp, H J Hodgson.   

Abstract

A patient with hepatic histological features of steatohepatitis in association with small bowel diverticulosis and bacterial overgrowth is described. A similar histological picture in the liver is well recognised in association with bacterial overgrowth in excluded loops of small intestine. Jejunal diverticulosis should be considered as a correlate of para-alcoholic hepatitis.

Entities:  

Mesh：

Year:  1989        PMID： 2516007

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN： 0172-6390


  22 in total

1.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

2.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

3.  The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.

Authors:  A J Wigg; I C Roberts-Thomson; R B Dymock; P J McCarthy; R H Grose; A G Cummins
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 4.  Microbiota and nonalcoholic steatohepatitis.

Authors:  Kento Imajo; Masato Yoneda; Yuji Ogawa; Koichiro Wada; Atsushi Nakajima
Journal:  Semin Immunopathol       Date:  2013-12-14       Impact factor: 9.623

Review 5.  Nonalcoholic fatty liver disease.

Authors:  Z M Younossi
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

6.  High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

Authors:  Jean-Marc Sabaté; Pauline Jouët; Florence Harnois; Charlotte Mechler; Simon Msika; Maggy Grossin; Benoît Coffin
Journal:  Obes Surg       Date:  2008-02-20       Impact factor: 4.129

7.  CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy.

Authors:  Daisuke Satoh; Takahito Yagi; Takeshi Nagasaka; Susumu Shinoura; Yuzo Umeda; Ryuichi Yoshida; Masashi Utsumi; Takehiro Tanaka; Hiroshi Sadamori; Toshiyoshi Fujiwara
Journal:  World J Hepatol       Date:  2013-04-27

8.  Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders.

Authors:  Srinevas K Reddy; Min Zhan; H Richard Alexander; Samer S El-Kamary
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

9.  The effect of a probiotic on hepatic steatosis.

Authors:  Steven F Solga; Gillian Buckley; Jeanne M Clark; Alena Horska; Anna Mae Diehl
Journal:  J Clin Gastroenterol       Date:  2008 Nov-Dec       Impact factor: 3.062

10.  Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

Authors:  H C Pinto; A Baptista; M E Camilo; A Valente; A Saragoça; M C de Moura
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.